Analystreport

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) had its price target lowered by analysts at Piper Sandler to $4.00.

NGM Biopharmaceuticals, Inc.  (NGM) 
Last ngm biopharmaceuticals, inc. earnings: 3/17 04:05 pm Check Earnings Report